Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$27.09 +0.13 (+0.47%)
Closing price 03:59 PM Eastern
Extended Trading
$26.94 -0.15 (-0.54%)
As of 06:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. STVN, IRTC, GKOS, BLCO, SLNO, TMDX, NVST, LIVN, INSP, and LQDA

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Inspire Medical Systems (INSP), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation.

93.2% of Warby Parker shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 18.2% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.19B6.58€127.45M€0.5448.04
Warby Parker$771.32M3.69-$20.39M-$0.07-386.96

Warby Parker has a consensus price target of $24.06, indicating a potential downside of 11.17%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.83
Warby Parker
0 Sell rating(s)
9 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.55

Stevanato Group has a net margin of 11.73% compared to Warby Parker's net margin of -1.12%. Stevanato Group's return on equity of 10.34% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.73% 10.34% 6.21%
Warby Parker -1.12%-0.79%-0.41%

Stevanato Group has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500.

In the previous week, Warby Parker had 9 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for Warby Parker and 8 mentions for Stevanato Group. Warby Parker's average media sentiment score of 1.48 beat Stevanato Group's score of 1.03 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
13 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Stevanato Group beats Warby Parker on 10 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.84B$33.50B$16.22B$21.34B
Dividend YieldN/A2.60%3.02%3.51%
P/E Ratio-386.9039.5418.0529.41
Price / Sales3.691.9255.4649.78
Price / Cash79.4116.5714.8924.46
Price / Book8.098.516.124.54
Net Income-$20.39M$1.23B$679.99M$999.91M
7 Day Performance7.22%1.93%3.51%0.86%
1 Month Performance15.91%6.18%4.90%5.13%
1 Year Performance95.15%41.41%6.37%16.56%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
1.5431 of 5 stars
$27.09
+0.5%
$24.06
-11.2%
+93.4%$2.84B$771.32M-386.903,780Positive News
Analyst Downgrade
STVN
Stevanato Group
N/A€25.53
+5.7%
N/A+29.0%€7.73B€1.19B47.285,521News Coverage
Positive News
IRTC
iRhythm Technologies
1.234 of 5 stars
$187.07
+3.3%
$163.82
-12.4%
+166.3%$5.82B$591.84M-63.852,000News Coverage
Positive News
GKOS
Glaukos
4.7285 of 5 stars
$91.83
-2.2%
$127.42
+38.7%
-29.8%$5.39B$432.95M-55.66780Positive News
Analyst Forecast
BLCO
Bausch + Lomb
2.328 of 5 stars
$15.50
+3.3%
$15.56
+0.3%
-2.7%$5.31B$4.79B-19.8813,500News Coverage
Positive News
SLNO
Soleno Therapeutics
4.3777 of 5 stars
$72.30
+3.6%
$115.09
+59.2%
+44.0%$3.71BN/A-17.4630Trending News
TMDX
TransMedics Group
3.2561 of 5 stars
$105.58
+1.5%
$122.11
+15.7%
-22.3%$3.55B$441.54M54.70210
NVST
Envista
3.6006 of 5 stars
$21.14
-0.8%
$20.92
-1.0%
+22.7%$3.54B$2.51B66.0512,300News Coverage
Positive News
LIVN
LivaNova
2.3065 of 5 stars
$58.32
+0.6%
$59.71
+2.4%
+24.7%$3.17B$1.25B-14.992,900News Coverage
Positive News
INSP
Inspire Medical Systems
4.9806 of 5 stars
$83.51
-3.4%
$164.50
+97.0%
-61.6%$2.56B$802.80M48.271,246Positive News
LQDA
Liquidia Technologies
3.495 of 5 stars
$27.98
-3.0%
$32.11
+14.8%
+201.8%$2.48B$14M-16.4650Positive News

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners